Medicare overpays for drugs while generic version is available
Healthcare Auditing Weekly, September 2, 2008
Medicare paid for drugs that had a cheaper generic version because of a time delay in calculating prices when the less expensive version came out, the OIG says.
Medicare paid double the average manufacturer’s sales prices for the cancer drug irinotecan after the generic version was cleared for sale Feb. 20, according the OIG’s report. The OIG estimated that if Medicare had based its payments on generic price, Medicare expenditures for this drug would have been reduced by $6.5 million in March 2008 alone.
The OIG is recommending CMS “explore options to expedite the process to ensure that Medicare payment amounts for drugs with newly available generic versions accurately reflect market prices.”
CMS agreed with the OIG’s findings and recommendations.
Comments
0 comments on “Medicare overpays for drugs while generic version is available ”
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Level of encryption needed for email
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- Capturing all necessary codes for IUD insertion and removal can be challenging
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Q&A: Acute respiratory failure diagnosis does not require intubation
- OB services: Coding inside and outside of the package
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- CMS has reformulated payments for some bilateral procedures
- Oxygen Cylinder Storage Requirements
- Q&A: Follow CMS' coding guidelines when using modifier -25
- Understand the spine to code back procedures correctly
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Searched
